Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Karo Bio/Merck & Co. form strategic alliance related to ER receptors

Nov. 5, 1997

FibroGen granted license to Zeneca antifibrotic compounds

Nov. 3, 1997

Genzyme General and Acadia enter drug discovery collaboration

Nov. 3, 1997

Laminin-like peptides available for licensing from NIH

Nov. 3, 1997

Genetic animal model of psychiatric disorders available for licensing

Oct. 30, 1997

Lilly and Chugai enter into combinatorial chemistry collaboration

Oct. 29, 1997

Dyax and Tularik establish drug discovery collaboration

Oct. 28, 1997

Structure of NO-producing enzyme solved

Oct. 28, 1997

Sibia's TBA technology licensed to Neurocrine Biosciences

Oct. 28, 1997

Atlantic's 2-5A improves efficacy of antisense compounds

Oct. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...